ArticleRheumatology and therapy2024

Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study.

Zhen-Wei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.